BioHedge Weekly Archive
13D/13G filings from biotech-focused institutional investors, cross-referenced with trial events and regulatory filings. Part of the RxDataLab platform — clinical trials, SEC filings, and hedge fund positioning, linked by company.
BioHedge Weekly: March 09 – March 16, 2026
3 SEC 13D/13G filings from biotech hedge funds: 0 new positions, 3 activist filings, 2 companies affected.
BioHedge Weekly: March 02 – March 09, 2026
4 SEC 13D/13G filings from biotech hedge funds: 0 new positions, 4 activist filings, 4 companies affected.
BioHedge Weekly: February 23 – March 02, 2026
3 SEC 13D/13G filings from biotech hedge funds: 0 new positions, 3 activist filings, 3 companies affected.
BioHedge Weekly: February 16 – February 23, 2026
69 SEC 13D/13G filings from biotech hedge funds: 8 new positions, 1 activist filings, 60 companies affected.
BioHedge Weekly: February 08 – February 15, 2026
8 SEC 13D/13G filings from biotech hedge funds: 1 new positions, 5 activist filings, 8 companies affected.
BioHedge Weekly: February 01 – February 08, 2026
3 SEC 13D/13G filings from biotech hedge funds: 1 new positions, 0 activist filings, 3 companies affected.
BioHedge Weekly: January 20 – January 27, 2026
4 SEC 13D/13G filings from biotech hedge funds: 1 new positions, 3 activist filings, 4 companies affected.